MRI Urged for High Breast Cancer Risk
American Cancer Society Recommends Annual Breast MRI for Very High-Risk Women
March 28, 2007 -- Women at very high risk of breast cancer -- fewer than 1
in 50 U.S. women -- should get yearly breast MRIs, the American Cancer Society
(ACS) now recommends.
Mammograms and ultrasound imaging have to scan through layers of tissue to
find budding breast cancers. But scans with MRI -- magnetic resonance imaging
-- provide detailed, cross-sectional images of the inside of the breast. It
finds more suspicious areas than other techniques.
The problem with MRI is that it is too good. That is, it finds a lot of
suspicious spots that turn out not to be breast cancer. For most women, routine
MRI screening would mean many unnecessary biopsies and a lot of unnecessary
It's a different story for women whose family histories or genetic
inheritance put them at very high risk of breast cancer. Suspicious MRI
findings in such women all too often turn out to be cancer. And early detection
is the key to cure.
That's why the ACS convened an expert panel to determine exactly which women
should -- and should not -- get regular MRI breast cancer screening. Panel
chair Christy Russell, MD, is co-director of the University of Southern
California breast center.
"These guidelines are a critical step to help define who should be
screened using MRI in addition to mammography," Russell says in a news
release. "Women at very high risk of breast cancer can be diagnosed much
earlier when combining the two technologies rather than using mammography
Which Women Need Breast MRI?
The ACS panel says women should get annual breast MRIs if:
- They carry mutations in the BRCA1 or BRCA2 breast cancer genes.
- They have a parent, sibling, or child with a BRCA1 or BRCA2 mutation, even
if they have yet to be tested themselves.
- Their lifetime risk of breast cancer has been scored at 20%-25% or greater,
based on one of several accepted risk-assessment tools that look at family
history and other factors.
- They had radiation to the chest between the ages of 10 and 30.
- They have a rare medical condition linked to breast cancer -- Li-Fraumeni
syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome -- or have a
parent, sibling, or child with one of these syndromes.
"The actual number of women seeking MRI screening in addition to
mammography is expected to be much lower than 1 in 50 -- at least for the
foreseeable future," say Debbie Saslow, PhD, ACS director of breast and
gynecologic cancer, and Robert Smith, PhD, ACS director of cancer screening, in
a statement released to WebMD.
Other women may benefit from MRI screening, but there's not yet enough
evidence to include them in the screening recommendation. The ACS says "the
jury is still out" on whether the benefits of MRI screening outweigh the
risks for women with:
- A 15%-20% lifetime risk of breast cancer, based on one of several accepted
risk-assessment tools that look at family history and other factors
- Lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)
- Atypical ductal hyperplasia (ADH)
- Very dense breasts or unevenly dense breasts (when viewed on a
- Previously diagnosed breast cancer, including ductal carcinoma in situ
The new recommendation comes with a warning: Not all doctors' offices have
the proper MRI equipment. Women should not get MRI screening at a practice that
does not also offer MRI-guided biopsies, the ACS warns.